Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Expression profiling by array | CNCHP | ||||||
GSE22965 |
Genome-wide analysis of Ollier disease: Is it all in the genes?
|
|
80 | Twinkal Chandubhai Pansuriya | Aug 26, 2011 | |||
GSE26675 |
Maffucci tumours
|
|
10 | Twinkal Chandubhai Pansuriya | Jul 19, 2011 | |||
GSE29774 |
Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations
|
|
18 |
|
Albert W Cheng | Jul 26, 2011 | ||
GSE30311 |
The histotype-specific copy-number landscape of ovarian cancer
|
|
200 |
|
Liang Goh | Oct 25, 2012 | ||
GSE30475 |
Colorectal Cancer Cells
|
35 | Keyan Salari | Nov 02, 2012 | ||||
GSE46848 |
The distribution of genomic variations in human iPSCs is related to replication timing reorganization during reprogramming
|
|
17 | Hu Li | Mar 28, 2014 | |||
GSE47917 |
Genome alterations in human pluripotent stem cells as very early events highly dependent on cell passaging conditions
|
|
30 | Qiang BAI | Jun 01, 2015 | |||
GSE55395 |
The distribution of genomic variations in human iPSCs is related to replication timing reorganization during reprogramming [Affymetrix]
|
|
14 | Hu Li | Mar 28, 2014 | |||
GSE56311 |
Integrative profiling of follicular lymphoma at diagnosis and relapse
|
|
123 |
|
Michael R Green | Mar 02, 2015 | ||
GSE66399 |
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with chemotherapy plus trastuzumab and lapatinib as neoadjuvant therapy for HER2-positive breast cancer
|
|
156 |
|
Enrico Tagliafico | Oct 06, 2015 | ||
GSE107513 |
The molecular basis of T-PLL is an actionable perturbation of TCL1/ATM- and epigenetically instructed damage responses
|
|
276 | Giuliano Crispatzu | Nov 30, 2017 | |||
GSE108476 |
The REMBRANDT study – a large collection of genomic data from brain cancer patients
|
|
2056 | Krithika Bhuvaneshwar | May 25, 2018 |